Skip to main content

Table 3 Barriers and facilitators to scale-up of differentiated antiretroviral therapy service delivery in Africa, 2021

From: Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: a scoping review

Factors

Barriers

Facilitators

Client, community, and service provider

â–ª Income and residence [59]

▪ Patients’ perception of the terms ‘unstable’ and ‘stable’ in DSD classification as provider stigma [59]

â–ª Stigma at the community level [59]

▪ Patients’ low literacy [58, 59]

â–ª The lack of buy-in from healthcare workers at both the facility and community levels [35]

â–ª The low energy required of providers to initiate or maintain change [38]

▪ The ART program staff’s perception of clubs not being core program work [38]

▪ Healthcare workers’ perception of having an increased workload when scaling up adherence clubs in a facility [38]

â–ª Low DSD delivery competence among health workers [59]

▪ Serving patients in community-based models was not seen as the facility’s responsibility [30]

â–ª The presence of patient education and peer support [47]

Resources (time, finance, information, space, drug, and workforce)

â–ª Inadequate drug supply [38, 47, 59]

â–ª Insufficient laboratory testing infrastructure [16]

â–ª Complaints about bad infrastructures, such as small rooms and a scarcity of off-site places [38], and no available comfortable seating for adherence club meetings [35]

â–ª Financial constraints [12, 25, 40, 54, 59]

â–ª In-efficient utilization of existing resources [40]

â–ª Inadequate number of staff [38]

â–ª Lack of time to allow the client and/or provider buy-in [25]

â–ª A consistent and flexible medication supply [45, 47]

â–ª The availability of functioning and reliable information system s[45, 47]

Leadership and governance

â–ª Weak health system [58]

â–ª Lack of effort to formalize plans [38]

â–ª Gaps in pharmacy supply chain management [16]

â–ª Inadequate forecasting of healthcare worker needs within DSD models [16]

â–ª Inadequate training, coordination, and compensation of community healthcare workers [16, 35, 38, 59]

â–ª The clash between DSD and tuberculosis appointment spacing [59]

â–ª Inconsistency in model uptake and adoption across models [16]

â–ª Problems of capacity related to the composition of the chronic dispensing unit system and the pharmaceutical dimension of clubs [38]

â–ª DSD not implemented in lower health facilities [59]

â–ª DSD lacked client-centeredness as designed [59]

â–ª The mix of the adherence club program with other HIV-negative patients [35]

â–ª Poor care linkages [47]

â–ª Inaccurate differentiating of patients based on clinical stability [16]

â–ª Lack of clarity regarding the ongoing role of the steering committee [38]

â–ª Political will at all levels of the health system [38]

â–ª Policies and guidelines development [47]

â–ª Strong care linkages [47]

â–ª Clear referral mechanisms between the community and health facility [45]

â–ª Provision of free care to access HIV-related services [45]

â–ª Availability of central chronic medicine dispensing and distribution program [26]

â–ª A sequence of events for stepwise model implementation [57]

â–ª Availability of training, strong supervision, and guidance related activities [25, 38, 45, 47]

â–ª Remuneration for lay workers involved in supporting community-based models [45]

â–ª Availability of a dedicated committee [38]

▪ The better approach of the clubs’ steering committee to guide adherence club eligibility and structure [27]

â–ª The collaborative implementation process [12]

â–ª Increased focus on person-centered care [25]

â–ª The presence of influential people in the steering committee [38]

â–ª Deployment of a nurse champion [38]

â–ª The influence of early adopter clinics on other clinics providing ART service [38]

Context

â–ª Extreme poverty conditions, particularly in rural areas [58]

â–ª Frequent changes in physical addresses (mobility) among urban clients [59]

â–ª Model flexibility [25]

  1. ART antiretroviral therapy, DSD differentiated service delivery